SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Claud B who wrote (6742)5/12/1999 8:37:00 PM
From: Dr. Voodoo   of 7041
 
Claud,

Tokyo is right. The NDA process isn't like sending off boxtops for Cracker Jack toys. No offense meant. The FDA is in regular communication with the people who file.

I don't believe the 'marketing' decision line. This is just not even remotely believable. I just can't believe if you're a doc your going to be looking at 'a few percent efficacy closer to viagra' before you write a script for vasomax.

Furthermore, Joe P. said in the conference call that he expected the non-approvable letter by the end of the week. Think about this. They likely submitted THOUSANDS of pieces of data to the FDA. If the FDA had not reviewed this carefully and found it not sufficient, they would not be able to put together this letter. Next, SGP and Zona felt going before the panel would be a waste of their own time. What the heck does attending a one day panel cost SGP? There is no amount of mathematics that I know of that says getting a better label out of this deal gets anybody more money in the long haul.

Sorry Joe P. I don't believe your story. You'll have to convince me otherwise. Waiting for options expiry and the non-approvable letter to arrive to short, hopefully I can get some shares at a price somewhere above 0.

Just my opinions Claud, no offenses meant.

V
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News